Pulmonx (LUNG) Non-Current Debt (2020 - 2025)

Pulmonx (LUNG) has reported Non-Current Debt for 6 consecutive years, with $37.0 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Non-Current Debt rose 8.78% year-over-year to $37.0 million in Q4 2025; TTM through Dec 2025 was $37.0 million, a 8.78% increase from a year earlier, with the FY2025 full-year figure at $37.0 million, up 8.78% from the prior year.
• Non-Current Debt was $37.0 million for Q4 2025 at Pulmonx, roughly flat from $37.1 million in the prior quarter.
• Over five years, Non-Current Debt peaked at $37.3 million in Q1 2023 and troughed at $179000.0 in Q4 2021.
• A 5-year average of $28.1 million and a median of $36.0 million in 2023 frame the typical range for Non-Current Debt.
• Across the five-year window, Non-Current Debt tumbled 68.26% in 2021 and soared 9527.93% in 2022, its largest moves.
• Over 5 years, Non-Current Debt stood at $179000.0 in 2021, then soared by 9527.93% to $17.2 million in 2022, then jumped by 103.6% to $35.1 million in 2023, then declined by 3.1% to $34.0 million in 2024, then gained by 8.78% to $37.0 million in 2025.
• The last three Non-Current Debt figures came in at $37.0 million (Q4 2025), $37.1 million (Q3 2025), and $37.1 million (Q2 2025), per Business Quant data.